Upper Respiratory Combinations

Multum Therapeutic Class Comparison, United States, 2022

Total Prescriptions in (2022)

Drug Name Total Prescriptions (2022) Percent Share
Dextromethorphan; Promethazine 1,088,232 21.8%
Brompheniramine; Dextromethorphan; Pseudoephedrine 1,039,412 20.9%
Codeine; Guaifenesin 862,861 17.3%
Loratadine; Pseudoephedrine 506,937 10.2%
Dextromethorphan; Guaifenesin 487,450 9.8%
Fexofenadine; Pseudoephedrine 342,583 6.9%
Codeine; Promethazine 181,218 3.6%
Chlorpheniramine; Phenylephrine 107,375 2.2%
Dextromethorphan; Guaifenesin; Phenylephrine 54,843 1.1%
Homatropine; Hydrocodone 45,484 0.9%
Hydrocodone; Chlorpheniramine 39,773 0.8%
Dexchlorpheniramine; Dextromethorphan; Phenylephrine 36,371 0.7%
Guaifenesin; Pseudoephedrine 30,783 0.6%
Chlorpheniramine; Dextromethorphan; Phenylephrine 30,391 0.6%
Codeine; Phenylephrine; Promethazine 26,799 0.5%
Brompheniramine; Dextromethorphan; Phenylephrine 19,849 0.4%
Dexbrompheniramine; Dextromethorphan; Phenylephrine 17,778 0.4%
Dextromethorphan; Pheniramine; Phenylephrine 16,261 0.3%
Pseudoephedrine; Triprolidine 13,177 0.3%
Chlorcyclizine; Pseudoephedrine 10,928 0.2%
Cetirizine; Pseudoephedrine 9,084 0.2%
Dexbrompheniramine; Phenylephrine 7,498 0.2%
Brompheniramine; Phenylephrine 6,062 0.1%

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time


Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Mailing List

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Biostatistics Rx - Medical literature evaluation and biostats WITHOUT the complex math and formulas
 
©2024 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021
Back to Top
Top